logo
logo
ASH stock ticker logo

Ashland Inc.

NYSE•ASH
CEO: Mr. Guillermo Novo
セクター: Basic Materials
業種: Chemicals - Specialty
上場日: 1980-03-17
Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; and nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives. Its Personal Care segment provides a range of natural, nature-derived, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers. The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding. Its Intermediates segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone. It offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, personal care, and pharmaceutical. The company was formerly known as Ashland Global Holdings Inc. and changed its name to Ashland Inc. in August 2022. Ashland Inc. was founded in 1924 and is headquartered in Wilmington, Delaware.
連絡先情報
8145 Blazer Drive, Wilmington, DE, 19808, United States
302-995-3000
www.ashland.com
時価総額
$2.29B
PER (TTM)
-3.3
28.2
配当利回り
3.3%
52週高値
$65.65
52週安値
$45.21
52週レンジ
23%
順位42Top 47.5%
3.9
F-Score
改良版 Piotroski 分析
10年ファンダメンタル
弱い • 3.9 / 9 ポイント
スコアレンジ (0-9)
8-9: 価値が優れている
6-7: 基礎体質が強い
4-5: 全体的に堅調
0-3: パフォーマンスが弱い
データ期間: 2016-2025

財務ダッシュボード

Q1 2026 データ

売上高

$386.00M-4.69%
直近4四半期の推移

EPS

-$0.26-92.57%
直近4四半期の推移

フリーCF

$111.00M-276.19%
直近4四半期の推移

2026 Q1 決算ハイライト

主なハイライト

Net Loss Significantly Narrows Net loss reduced to $(12)M for the quarter, a $153M improvement versus prior year period results.
Operating Cash Flow Strong Cash provided by operating activities from continuing operations reached $125M, up from $(30)M outflow last year.
Adjusted EBITDA Slight Dip Adjusted EBITDA was $58M, slightly down $3M from $61M, driven by portfolio optimization impacts.
Divestiture Impact on Sales Total sales were $386M, down $19M, reflecting an $11M volume drop and $10M impact from Avoca business sale.

リスク要因

Credit Rating Downgrade Risk Moody's Investor Services downgraded corporate credit rating to Ba2 during the quarter, potentially affecting future borrowing costs.
Lower Volume Pressures Sales Total sales decreased $19M, driven by lower volume and unfavorable pricing, partially offset by favorable foreign currency exchange.
Trade Policy Geopolitical Uncertainty Continuing regulatory activity regarding tariffs and global trade disputes creates macroeconomic and geopolitical uncertainty risks.
Asbestos Litigation Reserves Large Total reserves for Ashland's asbestos claims stood at $246M at period end, subject to future estimation changes.

見通し

FY2026 Adjusted EBITDA Narrowed Full year fiscal 2026 Adjusted EBITDA guidance narrowed to $400M to $420M range, reflecting temporary impacts.
Optimization Program Cost Savings Manufacturing optimization program on track, expecting $30M cost savings under the $90M program for fiscal 2026.
Core Markets Remain Resilient Personal Care and Life Sciences core end markets expected to remain resilient, supported by stable fundamentals and innovation traction.
Share Repurchase Availability High $520 million remained available for repurchase under the $1B evergreen stock repurchase program as of December 31, 2025.

同業比較

売上高 (TTM)

SID stock ticker logoSID
$7.96B
+4.0%
CC stock ticker logoCC
$5.81B
-0.1%
MEOH stock ticker logoMEOH
$3.59B
-3.4%

粗利益率 (最新四半期)

WDFC stock ticker logoWDFC
56.2%
+1.4pp
NGVT stock ticker logoNGVT
34.4%
+5.7pp
AVNT stock ticker logoAVNT
32.3%
-1.7pp

主要指標

銘柄コード
時価総額
PER (TTM)
ROE (TTM)
負債比率
MEOH$4.00B50.93.2%48.2%
SKE$3.77B-42.5-109.2%9.5%
AVNT$3.14B38.33.5%31.9%

長期トレンド

直近4四半期
売上高
純利益
営業キャッシュフロー
4四半期売上高CAGR
-6.9%
成長鈍化
4四半期純利益CAGR
N/M
収益構造の変化
キャッシュフロー安定性
100%
優れたキャッシュフローの実績

深度リサーチ

次回決算:2026年4月28日
|
EPS:-
|
売上高:-
財務データ
決算説明会
財務レポート
ニュース
損益計算書
バランスシート
キャッシュフロー計算書
財務比率
変化率
損益計算書
直近12ヶ月
データなし